Antigen binding and stability properties of non-covalently linked anti-CD22 single-chain Fv dimers

被引:20
|
作者
Arndt, MAE
Krauss, R
Rybak, SM
机构
[1] Univ Hosp Essen, Inst Immunol, D-45122 Essen, Germany
[2] NCI, SAIC, Frederick, MD 21702 USA
[3] NCI, Dev Therapeut Program, Frederick, MD 21702 USA
关键词
CD22; single chain Fv; diabody; dimer; stability;
D O I
10.1016/j.febslet.2004.11.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
By varying linker length and domain orientation three multivalent derivatives of a monovalent anti-CD22 single-chain fragment variable (scFv) antibody were generated. Shortening the linker of the V-H-V-L oriented scFv to 5 or 0 residues resulted in the formation of diabodies or a mixture of tetramers and trimers, respectively. Unexpectedly, a V-L-0-V-H scFv assembled to homogenous dimers, remained substantially more stable than the V-H-5-V-L diabody when incubated in human serum at 37 degreesC, and retained its dimeric state when concentrated up to 4 mg/ml. These properties suggest the V-L-0-V-H scFv could become an attractive vehicle for the selective delivery of multiple effector molecules to CD22(+) tumor cells. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:257 / 261
页数:5
相关论文
共 50 条
  • [31] The influence of peptide linker on the DNA and metal binding properties of single-chain fused dimers of the zinc sensor CzrA
    Lee, SB
    Giedroc, DP
    BIOPHYSICAL JOURNAL, 2005, 88 (01) : 407A - 407A
  • [32] Design and synthesis of germline-based hemi-humanized single-chain Fv against the CD18 surface antigen
    Caldas, C
    Coelho, VPCV
    Rigden, DJ
    Neschich, G
    Moro, AM
    Brígido, MM
    PROTEIN ENGINEERING, 2000, 13 (05): : 353 - 360
  • [33] Single-chain Fv with Fc fragment of the human IgG1 tag:: Construction, Pichia pastoris expression and antigen binding characterization
    de Andrade, EV
    de Albuquerque, FC
    de Moraes, LMP
    Brígido, MD
    Santos-Silva, MA
    JOURNAL OF BIOCHEMISTRY, 2000, 128 (06): : 891 - 895
  • [34] Pharmacokinetics and biodistribution of radioimmunoconjugates of anti-CD19 antibody and single-chain Fv for treatment of human B-cell Malignancy
    Quanzhi Li
    Wendy Hudson
    Duo Wang
    Erica Berven
    Fatih M. Uckun
    John H. Kersey
    Cancer Immunology, Immunotherapy, 1998, 47 : 121 - 130
  • [35] Optimization of conditions for formation and analysis of anti-CD19 FVS191 single-chain Fv homodimer (ScFv')(2)
    Wang, D
    Berven, E
    Li, QZ
    Uckun, F
    Kersey, JH
    BIOCONJUGATE CHEMISTRY, 1997, 8 (01) : 64 - 70
  • [36] Pharmacokinetics and biodistribution of radioimmunoconjugates of anti-CD19 antibody and single-chain Fv for treatment of human B-cell malignancy
    Li, QZ
    Hudson, W
    Wang, D
    Berven, E
    Uckun, FM
    Kersey, JH
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 47 (03) : 121 - 130
  • [37] Effects of humanization and gene shuffling on immunogenicity and antigen binding of anti-TAG-72 single-chain Fvs
    Pavlinkova, G
    Colcher, D
    Booth, BJM
    Goel, A
    Wittel, UA
    Batra, SK
    INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (05) : 717 - 726
  • [38] Improved antigen binding by a CD20-specific single-chain antibody fragment with a mutation in CDRH1
    Adamson, PJ
    Millard, DJ
    Hohmann, AW
    Mavrangelos, C
    Macardle, PJ
    Pilkington, G
    Mulhern, TD
    Tedder, TF
    Zola, H
    Nicholson, IC
    MOLECULAR IMMUNOLOGY, 2006, 43 (06) : 550 - 558
  • [39] BINDING-AFFINITY AND INHIBITORY PROPERTIES OF A SINGLE-CHAIN ANTI-T-CELL RECEPTOR ANTIBODY
    SCHODIN, BA
    KRANZ, DM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (34) : 25722 - 25727
  • [40] Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange
    Wu, AM
    Tan, GJ
    Sherman, MA
    Clarke, P
    Olafsen, T
    Forman, SJ
    Raubitschek, AA
    PROTEIN ENGINEERING, 2001, 14 (12): : 1025 - 1033